Intezyne Technologies Expands Its Oncology Pipeline Through Strategic Acquisition of Niiki Pharma

By WebmasterJune 19, 2013November 1st, 2024No Comments

Intezyne Technologies Expands Its Oncology Pipeline Through Strategic Acquisition of Niiki Pharma
Read more here

Previous PostActelion enters into an agreement to acquire privately-held Ceptaris Therapeutics
Next PostNovira Therapeutics Expands Management Team